Best impact factor ever and CPHEN, a new acronym for a successful manuscript type

I am happy and proud to share with you the latest performance results of Cytometry Part A according to Clarivates' Web of Science. Our 2021 2-Year Impact Factor is now at 4.714, even surpasses the historically highest 2-Year IF value from 2020 [1]. In the “Biochemical Research Methods” category, we ranked 21 out of 79 journals and improved our ranking in the subject category “Cell Biology” to 97/194 (the year before was 103/195). I cannot thank the whole team of scientific editors from our editorial board and the peer reviewers enough for their tireless dedication supporting cytometry with their outstanding expertise to achieve the highest possible quality. My thanks go to the excellent team at John Wiley and Sons who exquisitely handled the process of manuscript and journal issue management. The times remained difficult but the team helped to smoothly and swiftly adapt to the new situation and implement the necessary changes. Concurrently, a journal would not be anything without the community's contributions, discussions, and proposals. Thank you for all your support! One indicator of the Clarivate statistic is of particular interest, the self-citation rate. This number indicates which percentage of the cites is due to self-citation. The lower this number the higher is the journal cited by other journals. This year we have the historical lowest self-citation index: 9.35 (in the previous 20+ years it was 23 in the mean). This means that Cytometry Part A receives increasing attention from the outside scientific community, a good signal. 2 | CPHEN, THE NEW ACRONYM FOR PHENOTYPE REPORTS MANUSCRIPT CATEGORY